Back to Search
Start Over
EE79 A Cost of Control Analysis of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide for Bringing Patients to Treatment Targets in China.
- Source :
-
Value in Health . 2022 Supplement, Vol. 25 Issue 7, pS350-S350. 1p. - Publication Year :
- 2022
- Subjects :
- *COST control
*COST analysis
*SEMAGLUTIDE
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 25
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 157695363
- Full Text :
- https://doi.org/10.1016/j.jval.2022.04.333